GlassScriptPhysician profile
Harriet Kisuve
NPI 1568835684
$1,351.05
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $403 · 2023: $248 · 2024: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $320.07 | 2021-2023 | Xarelto |
| Ucb, INC. | $271.70 | 2021-2024 | Briviact |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.25 | 2022-2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.43 | 2022-2024 | Jardiance, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $77.60 | 2021-2024 | |
| Inari Medical, INC. | $57.10 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Mallinckrodt Hospital Products INC. | $42.51 | 2024 | Terlivaz |
| Merck Sharp & Dohme LLC | $41.63 | 2024 | Verquvo, Recarbrio, Dificid |
| Pfizer INC. | $39.41 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $37.91 | 2022 | |
| Melinta Therapeutics, LLC | $36.59 | 2021-2022 | |
| Novo Nordisk INC | $32.45 | 2022-2023 | |
| Kyowa Kirin, INC. | $21.00 | 2024 | Crysvita |
| Xeris Pharmaceuticals, INC. | $19.94 | 2023 | Gvoke Hypopen |
| Abbvie INC. | $19.29 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.38 | 2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $14.35 | 2021 | |
| Alexion Pharmaceuticals, INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harriet Kisuve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.